We believe that key to the success of a pricing strategy is reimbursement. A clear understanding of how the product will be paid and who will pay for it is essential to successful market access. Payment policies and potential changes should be understood before the target product profile is established. In a global marketplace, health care reimbursement is managed differently across countries in the EU and Asia with diverse terminology and polices.
The need for policy research to anticipate shifts in the reimbursement landscape is essential for the success of a product access strategy. MKTXS Research includes:
- Examining reimbursement decision-making of regulatory groups in the US and EU Countries, public policy issues, likely reimbursement levels and restrictions based on existing regulations
- Examination of country requirements for cost effectiveness, quality of life, and budgetary impact data and analyses beyond evidence of safety and efficacy
- Exploration of other market access hurdles such as prescription restrictions and treatment guidelines and special funds to pay for medicines
Our reimbursement research services address the following situations:
- Reimbursement Assessment
- Analysis of Reimbursement Issue
- Understanding Changing Reimbursement Environment
- Formulary Entry Strategy
- Reimbursement Barriers
- Monitor Product Reimbursement
